GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » Valuation Rank

Eckert & Ziegler SE (XTER:EUZ) Valuation Rank


View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Eckert & Ziegler SE Valuation Rank Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Eckert & Ziegler SE (XTER:EUZ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » Valuation Rank
Comparable Companies
XTER:SBS XTER:GME XTER:AAQ1 ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH STE ALGN XSWX:SOON SHSE:688271 ASX:COH PODD SWAV
Traded in Other Exchanges
1EUZ:Italy 0NZY:UK
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, D-13125
Website
https://www.ezag.com
Eckert & Ziegler Strahlen- und Medizintechnik AG is a provider of isotope technology for medical, scientific and industrial use. It is primarily engaged in the business activities of cancer therapy, industrial radiometry, and nuclear-medical imaging. The business segments of the group are Isotope products; Medical and Holding company. The company generates maximum revenue from Isotope products segment. Geographically, it derives a majority of revenue from Europe and also has a presence in North America, Asia-Pacific, and other regions.
Executives
Dr. Andreas Eckert Supervisory Board
Frank Perschmann Supervisory Board
Dr. Hakim Bouterfa Board of Directors
Prof. Dr. Wolfgang Maennig Supervisory Board
Dr. Harald Hasselmann Board of Directors